Peru’s efforts to arrange for a phase 3 clinical trial for a potential COVID-19 vaccine developed by China National Pharmaceutical Group (Sinopharm) have been hailed by China.
The move showcases a high degree of trust between the two nations, said Chinese State Councillor and Foreign Minister Wang Yi said on November 5 in a telephonic conversation with Peruvian Foreign Minister Mario Lopez. Adding further he said that China understands and supports Peru’s need to purchase COVID-19 vaccines.
He further reiterated China’s commitment to make the vaccine a global public good and to provide it to the developing nations on a priority basis. He also notes that next year both the nations will mark the 50th anniversary of the diplomatic ties between the two.